AGENUS INC AGEN

Latest FY: 2025 Healthcare Biotechnology
Market Price $8.22
Market Cap $343.13M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑10.4% YoY
$114.20M
3-Yr CAGR: 5.2%
Net Income ↑100.0% YoY
-$101.00K
Net Margin: -0.1%
Free Cash Flow ↑51.4% YoY
-$77.20M
FCF Yield: -22.50%
EPS (Diluted) ↑100.0% YoY
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: -0.0%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AGEN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $22.6M $-74.4M $-127.0M $-1.46 0.00% $-80.0M $-92.5M
FY 2017 $42.9M +89.9% $-70.1M $-120.7M +5.0% $-1.23 +15.8% 0.00% $-94.2M $-97.3M -5.3%
FY 2018 $36.8M -14.2% $-86.5M $-159.9M -32.5% $-1.44 -17.1% 0.00% $-131.1M $-134.7M -38.4%
FY 2019 $150.0M +307.9% $-24.1M $-107.9M +32.5% $-0.80 +44.4% 0.00% $-18.7M $-23.3M +82.7%
FY 2020 $88.2M -41.2% $85.8M $-181.1M -67.9% $-1.05 -31.2% 0.00% $-139.1M $-142.6M -510.8%
FY 2021 $295.7M +235.3% $292.2M $-24.1M +86.7% $-0.11 +89.5% 0.00% $10.1M $-23.7M +83.4%
FY 2022 $98.0M -66.8% $87.5M $-220.3M -812.6% $-0.78 -609.1% 0.00% $-175.4M $-228.4M -865.1%
FY 2023 $156.3M +59.5% $153.2M $-246.0M -11.7% $-0.69 +11.5% 0.00% $-224.2M $-234.2M -2.5%
FY 2024 $103.5M -33.8% $103.0M $-227.4M +7.5% $-10.59 -1,434.8% 0.00% $-158.3M $-158.9M +32.1%
FY 2025 $114.2M +10.4% $58.6M $-0.1M +100.0% +100.0% 0.00% $-77.2M $-77.2M +51.4%
$

Valuation

Market Price $8.22
Market Cap $343.13M
Enterprise Value $384.79M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -22.50%
Dividend Yield N/A
Shares Outstanding 41,642,400
%

Profitability & Margins

Gross Margin 51.30%
Operating Margin -17.66%
Net Margin -0.09%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -0.04%
Asset Turnover 0.50x
Revenue 3-Yr CAGR 5.22%
🛡️

Financial Health & Liquidity

Current Ratio 0.41
Cash Ratio 0.01
Debt / Equity -0.165
Debt / Assets 0.197
Cash & Equivalents $3.00M
Total Debt $44.66M
Book Value / Share $-6.51
💧

Cash Flow Efficiency

Operating Cash Flow -$77.19M
Capital Expenditures (CapEx) $6.00K
Free Cash Flow -$77.20M
OCF / Revenue -67.60%
FCF / Revenue -67.60%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-6.51
EPS YoY Growth 100.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $226.80M
Total Liabilities $497.91M
Stockholders' Equity -$271.11M
Current Assets $133.44M
Current Liabilities $323.49M